Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F0A2U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp for VYNDAMAX 61 mg capsules (30-count unit dose packaging) on January 26, 2026, with an ultimate completion date of February 17, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to military healthcare programs globally.
VYNDAMAX (dluroloxifene), indicated for cardiovascular disease prevention in postmenopausal women, represents one of numerous pharmaceutical deliveries that AmerisourceBergen fulfills for federal military and veteran healthcare systems. As a major pharmaceutical distributor, the company maintains extensive federal contract experience supplying specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract demonstrates AmerisourceBergen's critical role in the defense pharmaceutical supply chain, enabling it to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible purchasing arrangements aligned with military medical requirements.
Quick answers
Who was awarded contract SPE2DR26F0A2U?
SPE2DR26F0A2U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F0A2U worth?
The government has obligated $14,593 on SPE2DR26F0A2U.
Is contract SPE2DR26F0A2U an order under another contract?
Yes. SPE2DR26F0A2U is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A2U competed?
The extent of competition for SPE2DR26F0A2U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award